Top Back to top

Haploidentical stem cell transplantation using PTCY for children with acute leukemia

Study number:
8417027
Short title:
PT-Cy based haploidentical HSCT for Acute Leukemia
Study status:
Ongoing
Deadline for data collection:
 
Study design:
Retrospective registry based analysis
Primary objective:
Primary end point:
Leukemia-free survival (LFS)

Secondary end points are:
Haematopoietic recovery, grades II-IV and grade III-IV GVHD, chronic GVHD, transplantation-related mortality, relapse, GRFS and OS
Key inclusion criteria:
1) Patient age less/= than 18 years
2) Patient diagnosed with either ALL or AML
3) Patient who underwent a first allograft between 2010 and 2016 included.
4) Patient which received unmanipulated (non TCD) haploidentical stem cell transplantation
5) Post-transplant cyclophosphamide as GVHD prophylaxis

Country:
Italy
Principal investigator:
Annalisa Ruggeri
Principal investigator email:
annalisaruggeri80@hotmail.com
EBMT Study coordinator:
Arnaud Dalissier
Study coordinator email:
arnaud.dalissier@upmc.fr

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org